Entera Bio Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Entera Bio Ltd. (ENTX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents8.6611.0212.3124.898.5915.1911.52
Cash & Short-Term Investments8.6611.0212.3124.898.5915.1911.52
Accounts Receivable0.130.000.250.180.260.280.73
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.190.240.290.250.260.170.09
Total Current Assets8.9711.2612.8525.339.1115.6412.47
Non-Current Assets
Property, Plant & Equipment (Net)0.330.490.230.400.570.200.22
Long-Term Investments0.080.000.000.000.000.000.00
Other Non-Current Assets0.090.010.010.050.050.260.00
Total Non-Current Assets0.420.510.280.660.611.070.88
Total Assets9.3911.7713.1325.999.7216.7013.34
Current Liabilities
Accounts Payable0.130.080.022.970.161.701.23
Short-Term Debt0.170.000.000.000.000.000.00
Accrued Liabilities0.870.500.932.671.330.000.00
Deferred Revenue0.000.000.000.020.160.000.00
Other Current Liabilities0.870.000.000.001.432.441.37
Total Current Liabilities1.181.091.343.161.844.593.16
Non-Current Liabilities
Long-Term Debt0.100.260.000.120.240.120.00
Other Non-Current Liabilities0.030.000.000.009.0111.470.00
Total Non-Current Liabilities0.130.290.030.260.370.190.07
Total Liabilities1.311.381.373.422.214.783.23
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-113.93-104.39-95.50-82.39-70.24-62.87-52.12
Accumulated Other Comprehensive Income0.040.040.040.040.040.0013.06
Additional Paid-in Capital121.97114.73107.21104.9577.7163.3949.17
Shares Outstanding38.8435.4828.8128.800.000.000.00
Total Stockholders' Equity8.0810.3911.7522.577.5111.9210.12
Total Liabilities & Equity9.3911.7713.1325.999.7216.7013.34